Search research articles
Contact Us
Filters
Showing results (11-20 of 126) with videos related to
Page
of 13
Sort By:
Internal Medicine Journal
|
April 13, 2026
Outcomes of patients with unresectable or metastatic melanoma after cessation of immunotherapy following complete metabolic response or toxicities
Nur Sakinah Zulkifli, Laura Tam, Andrew McLean, et al.
The Medical Journal of Australia
|
October 31, 2018
Endemic unprofessional behaviour in health care: the mandate for a change in approach
Johanna Westbrook, Neroli Sunderland, Victoria Atkinson, et al.
Heart, Lung & Circulation
|
April 1, 2008
Cutaneous microangiopathic thrombosis complicated by pyoderma gangrenosum in post-cardiac surgery heparin-induced thrombocytopaenia
Suvitesh Luthra, Sanjay Theodore, Matthew Liava'a, et al.
Internal Medicine Journal
|
October 19, 2021
Non-sclerosing large duct cholangitis secondary to checkpoint inhibition
Andrew W C Teo, Victoria Atkinson, Greg Miller, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
December 10, 2003
Words used by children and their primary caregivers for private body parts and functions
Dennis Scolnik, Victoria Atkinson, Maha Hadi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 30, 2020
The concepts of rechallenge and retreatment in melanoma: A proposal for consensus definitions
Christoffer Gebhardt, Paolo Ascierto, Victoria Atkinson, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
March 29, 2011
Expanding cardiac pseudotumor
Krishna Bhagwat, Jane Hallam, Gangahanumaiah Shivanand, et al.
Asia-Pacific Journal of Clinical Oncology
|
April 14, 2015
Radiotherapy utilization in BRAF mutation-tested metastatic melanoma in the targeted therapy era
Peter Gorayski, Marcin Dzienis, Matthew Foote, et al.
JAAD Case Reports
|
October 16, 2018
Tumoral melanosis associated with combined <i>BRAF</i>/<i>MEK</i> inhibition (dabrafenib/trametinib) in metastatic melanoma
Antonia Laino, Benjamin Shepherd, Victoria Atkinson, et al.
Pharmacoepidemiology and Drug Safety
|
April 11, 2021
Survival of advanced melanoma patients treated with immunotherapy and targeted therapy: A real-world study
Su-Yeon Yu, Dan Mckavanagh, Ian McPherson, et al.
Page
of 13
Search research articles
Search
Showing results (11-20 of 126) with videos related to
Sort By:
Page
of 13
Internal Medicine Journal
|
April 13, 2026
Outcomes of patients with unresectable or metastatic melanoma after cessation of immunotherapy following complete metabolic response or toxicities
Nur Sakinah Zulkifli, Laura Tam, Andrew McLean, et al.
The Medical Journal of Australia
|
October 31, 2018
Endemic unprofessional behaviour in health care: the mandate for a change in approach
Johanna Westbrook, Neroli Sunderland, Victoria Atkinson, et al.
Heart, Lung & Circulation
|
April 1, 2008
Cutaneous microangiopathic thrombosis complicated by pyoderma gangrenosum in post-cardiac surgery heparin-induced thrombocytopaenia
Suvitesh Luthra, Sanjay Theodore, Matthew Liava'a, et al.
Internal Medicine Journal
|
October 19, 2021
Non-sclerosing large duct cholangitis secondary to checkpoint inhibition
Andrew W C Teo, Victoria Atkinson, Greg Miller, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
December 10, 2003
Words used by children and their primary caregivers for private body parts and functions
Dennis Scolnik, Victoria Atkinson, Maha Hadi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 30, 2020
The concepts of rechallenge and retreatment in melanoma: A proposal for consensus definitions
Christoffer Gebhardt, Paolo Ascierto, Victoria Atkinson, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
March 29, 2011
Expanding cardiac pseudotumor
Krishna Bhagwat, Jane Hallam, Gangahanumaiah Shivanand, et al.
Asia-Pacific Journal of Clinical Oncology
|
April 14, 2015
Radiotherapy utilization in BRAF mutation-tested metastatic melanoma in the targeted therapy era
Peter Gorayski, Marcin Dzienis, Matthew Foote, et al.
JAAD Case Reports
|
October 16, 2018
Tumoral melanosis associated with combined <i>BRAF</i>/<i>MEK</i> inhibition (dabrafenib/trametinib) in metastatic melanoma
Antonia Laino, Benjamin Shepherd, Victoria Atkinson, et al.
Pharmacoepidemiology and Drug Safety
|
April 11, 2021
Survival of advanced melanoma patients treated with immunotherapy and targeted therapy: A real-world study
Su-Yeon Yu, Dan Mckavanagh, Ian McPherson, et al.
Page
of 13